Clinical Trial Update: A Phase II Trial of 72-Hour Continuous IV Infusion of 9-Aminocamptothecin With G-CSF Support in Patients With Advanced Ovarian Cancer Previously Treated With Paclitaxel and Cisplatin [Phase 2]

View source ↗

Summary

Phase II results of a 72-hour continuous intravenous infusion of 9-aminocamptothecin with G-CSF support in patients with advanced ovarian cancer previously trea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• 9-Aminocamptothecin (9-aminocamptothecin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Ovarian Neoplasms | Phase 2 | Status: COMPLETED